I'm talking about the phase 2. We had PFS, and that is what got everybody excited. OS would have been better, but the patients and data needed more time. Supposedly, those numbers were to come. Statistically significant OS would get the world talking again. And, pardon me for noticing, we could use the boost. Just when? is my question.